Thomas Smith

Senior Regional Business Director at Calliditas Therapeutics

Thomas Smith has a diverse work experience spanning several companies. Thomas began their career in 2003 at Pitney Bowes as a Sales Executive and District Solutions Sales Specialist, where they were responsible for maintaining and growing major accounts and leading the launch of a new machine. In 2005, they became District Sales Manager at Pitney Bowes, leading a team of sales professionals during a period of transition and natural disasters.

In 2006, Thomas joined Shire as a Professional Sales Representative in the Nephrology Specialty. Thomas quickly advanced through various roles and was promoted to Senior Sales Representative in the GI Specialty division. In this role, they were responsible for the successful launch of the Lialda product and served as an Interim Regional Director. Thomas also organized events and worked with medical societies.

Thomas continued to excel at Shire, eventually becoming Senior Regional Business Director. Thomas led a cross-functional team in the ultra-rare disease space and successfully merged representatives from two regions into one high-performing and inclusive team. Thomas was recognized for their leadership and business acumen, winning awards and serving as a leadership ambassador.

In 2019, Thomas joined Takeda as Senior Regional Business Director in the GI Rare Disease division. Thomas navigated company acquisitions, realignments, and the COVID-19 pandemic while leading and developing the Southeast region. Thomas achieved exceptional results and was recognized for their leadership, winning awards and being appointed as a GIBU Leadership Ambassador.

Most recently, in 2021, Thomas joined Calliditas Therapeutics AB as a Regional Business Director.

Thomas Smith obtained a Bachelor's degree from the University of New Orleans. Additionally, they received a certification in Adaptability & Resilience from McKinsey & Company in February 2021. No specific start or end years were provided for their education at the University of New Orleans.

Location

Orlando, United States

Links

Previous companies


Org chart


Teams


Offices

This person is not in any offices


Calliditas Therapeutics

2 followers

Calliditas Therapeutics AB is a specialty pharmaceutical company based in Stockholm, Sweden. It is focused on developing high quality pharmaceutical products for patients with a significant unmet medical need in niche indications, in which Calliditas can partially or completely participate in the commercialization efforts. Calliditas is focused onthe development and commercialization of the product candidate Nefecon, a unique two step formulation optimized to combine a time lag effect with a concentrated release of the active substance budesonide, within a designated target area. This patented, locally acting formulation is intended for treatment of patients with the inflammatory renal disease IgA nephropathy (IgAN). Calliditas is running a global Phase 3 study within IgAN and aims to commercialize Nefecon in the United States.


Headquarters

Stockholm, Sweden

Employees

51-200

Links